Categories
-
Adhesives
6
Amines
101
Amino Acids
185
Analytical Reagents
714
Antibiotics
255
Bioactive Small Molecules
742
Aroma Chemicals
213
Biochemicals
1051
Boronic Acids
4
Buffers
98
Building Blocks
1928
Carbohydrates
180
Catalysts
111
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
262
Flavours and Fragrance Materials
214
Fluorinated Products
51
Furans
6
Gases in Solution
49
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
345
Ion-Pair Reagents
24
Ligands
80
Organics
1440
Oxazoles
3
Peptide Reagents
91
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
108
Research Organics & Inorganics
804
Salts
299
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
305
Sugars
64
Tailor-made solutions
1
Testing Standards
4
Uncategorised
30
Water Analysis
13
Ferrozine (3-(2-Pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine) sodium salt
(39880879 | 69898-45-9)
CAS: | 69898-45-9 |
---|---|
Molecular Formula: | C20H13N4NaO6S2 |
Molecular Weight: | 492.46 |
Availablility: | In Stock |
---|---|
Downloads: | | |
39880879-5g | 5g | £210.00 | |
Bulk Order |
39880879-5g | 5g | €294.00 | |
Bulk Order |
39880879-5g | 5g | $315.00 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 39880879 | ||||
Product Name | Ferrozine (3-(2-Pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine) sodium salt | ||||
Categories | Analytical Reagents Biochemicals Diagnostic Raw Materials | ||||
CAS | 69898-45-9 | ||||
Molecular Formula | C20H13N4NaO6S2 | ||||
Molecular Weight | 492.46 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29336980 |
Product Specification
Moisture | 5.0 - 8.0% | ||||
Iron Content | ≤5ppm | ||||
Appearance | Yellow Powder | ||||
Assay (calculated on the dried basis) | ≥95.0% | ||||
Emax 283 | ≥22000 | ||||
E max 562 | ≥27,000 |
Safety Information
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|